1629 results for Leukemia
Refine Your Search
New Insights & Treatments for Leukemia
New Insights & Treatments for Leukemia To register or For more information, please contact Mary Walls, Patient Access Manager, mary.wal…
LGL Leukemia Registry at UVA
To learn more about this rare form of blood cancer and how to treat it. Based at the University of Virginia Cancer Center in Charlottesville, un…
Links For Leukemia Golf Tournament
24th Annual Links Fore Leukemia Golf Tournament Monday, June 15, 2020 Gleneagle's County Club, King's Course
Living with Hairy Cell Leukemia
Presentation Click Here Topics Covered We invite you to learn more about: Diagnosis and current treatment options for hairy cell leukemia …
Advances in Chronic Myeloid Leukemia
[Click here to enlarge.] Topics Covered We invite you to learn more about: Audio Replay …
Advances in Acute Myeloid Leukemia
Topics Covered We invite you to learn more about: Audio Replay …
Juvenile myelomonocytic leukemia (JMML)
JMML is an uncommon blood cancer that is most commonly diagnosed in infants and children younger than 4 years old.
Blood Cancer
Chronic myelomonocytic leukemia (CMML)
CMML is a rare blood cancer that has overlapping features of two other types of blood cancers: MDS and MPNs. CMML is rare in children.
Blood Cancer
Hairy cell leukemia (HCL)
HCL is a rare, slow-growing type of blood cancer that starts in a B cell and gets its name from the short, thin projections that look like hair on its…
Blood Cancer
Chronic lymphocytic leukemia (CLL)
CLL is a blood cancer of the bone marrow that can progress quickly or slowly, depending on the form it takes.
Blood Cancer
Developing novel therapeutic approaches for classical and variant hairy cell leukemia
In this proposal, we have combined clinical and research expertise in HCL across Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College…
Immunotherapy Greatly Improves Survival for Infants with an Aggressive Form of Leukemia
These results mark a big step forward in the treatment of infants with this form of Acute Lymphoblastic Leukemia (ALL).
News Release
LLS PedAL: Precision Medicine for Children with Leukemia
As part of The LLS Children’s Initiative, LLS is working with a team of renowned pediatric oncologists to lay the groundwork for a global precision me…
New Targeted Therapies for Pediatric Acute Myeloid Leukemia
Our research focuses on the preclinical evaluation of new targeted therapies for high-risk subtypes of childhood AML. We are deploying screening appro…
Targeting mitochondrial dynamics in venetoclax-resistant acute myeloid leukemia
Although new targeted therapies have been discovered and approved for the treatment of various types of leukemia, in many cases patients do not respon…
Investigating and targeting the histone acetylation reader protein ENL in acute leukemias
Leukemia often results from aberrant gene expression caused by epigenetic alterations. Previously we discovered a novel histone acetylation reader dom…
Precision Medicine Inhibitor and Immunotherapy Approaches for High-Risk Childhood Leukemias
Dr Tasian’s scientific passion is successful development of precision medicine therapies for high-risk childhood leukemia. Her translational laborator…
Strategic combinations to overcome therapeutic resistance and relapse in acute myeloid leukemia
Acute myeloid leukemia (AML) is the most fatal type of leukemia and has a high rate of relapse following current therapies. We have recently uncovered…
Chronic myeloid leukemia (CML) treatment
Treatment for CML differs depending on the phase of the CML.
Blood Cancer
Chronic myeloid leukemia (CML) diagnosis
To diagnose CML, doctors use a variety of tests to analyze blood and bone marrow cells.
Blood Cancer
T cell acute lymphoblastic leukemia accumulation in the central nervous system
T cell acute lymphoblastic leukemia (T-ALL) has a strong tendency to infiltrate the central nervous system (CNS). The goal is hope to develop strategi…
Understanding AML vs. ALL: Navigating the complex field
Table of contents: Understanding AML vs. ALL: Navigating the complex fieldSimilarities and differences between AML and ALLCauses and risk factors: Und…
Adolescent & Young Adult Cancer Awareness Week: Free Support & Financial Resources from The Leukemia & Lymphoma Society for Blood Cancer Patients, Survivors, Families & Caregivers
Here at The Leukemia & Lymphoma Society (LLS), we hear every day from blood cancer patients, families, and caregivers of all ages and from all walks o…
Precision targeting of BFL-1 and MCL-1 in pediatric leukemias to overcome treatment resistance
Pediatric leukemia cells hijack the BCL-2 family signaling network to overexpress a range of anti-apoptotic proteins, including BFL-1 and MCL-1, and t…
Glycotyping as a novel approach to study leukemia stem cell heterogeneity and function
Leukemia stem cells (LSCs) are highly heterogeneous populations and key contributors to AML progression. Here, I aim to employ heparan sulfate (HS) gl…